Medicared For All Logo

Saeid Safaee MD in Glendale, California

Home California Glendale

Saeid Safaee MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 1511 W Glenoaks Blvd in Glendale, California. There is an additional office location, for a total of two, for Saeid Safaee MD that can be viewed further down.

They're a part of the: Southern California Pulmonary And Critical Care Associates, Inc. medical group which has around 4 members. You can call their office at 818-637-2200 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1987 (around 37 years of experience). They are listed as doing telehealth appointments.


Saeid Safaee MD Office Phone and Directions

Saeid Safaee MD
Southern California Pulmonary And Critical Care Associates, Inc.
1511 W Glenoaks Blvd
Glendale, California 91201
818-637-2200


Patient Ratings
Please rate your experience with Saeid Safaee MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 818-637-2200


Enter a starting address:


Healthcare Info for Saeid Safaee MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Saeid Safaee MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 4789618927
NPI #: 1437112604
NPI Created On: 04/10/2006
NPI Last Updated Listed as: 09/24/2020
Primary Taxonomy Code: 207RP1001X
License Number:
C-53279
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Removal of fluid from chest cavity with imaging guidance
  2. X-ray of chest, 2 views
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
  5. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
  6. Determination of lung volumes using plethysmography
  7. Measurement of lung diffusing capacity
  8. New patient office or other outpatient visit, typically 45 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Initial hospital inpatient care, typically 70 minutes per day
  12. Subsequent hospital inpatient care, typically 25 minutes per day
  13. Subsequent hospital inpatient care, typically 35 minutes per day
  14. Hospital discharge day management, more than 30 minutes
  15. Critical care delivery critically ill or injured patient, first 30-74 minutes
  16. Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788230195

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795922585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795922581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795922589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795922593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801631597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801632617

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801635609

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801637011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802132598

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Additional Office Locations

1. Vista Critical Care Associates Inc
1511 W Glenoaks Blvd
Glendale, CA 91201
Group Members: 10


Enter a starting address:


Pulmonary Disease Professionals in Glendale

1500 S Central Ave
Glendale, CA

1030 S Glendale Ave
Glendale, CA

1511 W Glenoaks Blvd
Glendale, CA
Vista Critical Care Associates Inc

1505 Wilson Ter
Glendale, CA
Altitude Pulmonary And Critical Care Associates

1511 W Glenoaks Blvd
Glendale, CA
Vista Critical Care Associates Inc

1511 W Glenoaks Blvd
Glendale, CA
Southern California Pulmonary And Critical Care Associates, Inc.

Providers in Southern California Pulmonary And Critical Care Associates, Inc.

1.Sevak Aghazaryan

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Nurse Practitioner

2.Gayane Mkrtchyan

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Nurse Practitioner

3.Saeid Safaee Md

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Pulmonary Disease

4.Lusine Simonyants

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Pulmonary Disease

View all 4 members of Southern California Pulmonary And Critical Care Associates, Inc. medical group